Phase 3 trial for Progressive MS

Hi, This might interest some of you... https://multiplesclerosisnewstoday.com/news-posts/2020/12/17/progressive-ms-patients-enroll-phase-3-trials-tolebrutinib/ Extract: Those who wish to know more information about the studies, including their eligibility to enroll, may contact Sanofi by email at [email protected], or by phone at 800-633-1610 (extension option six).